September 2016

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03



Broad Agency Announcement has been updated.  See new link at right.
Ongoing All Ranks Federal See BAA

United States Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement for Extramural Medical Research
W81XWH-16-R-BAA1

The mission of the USAMRMC is to provide solutions to medical problems of importance.  Projects must be for basic and applied research. Projects must be for scientific study and experimentation directed toward advancing the state of the art or increasing knowledge or understanding.  (See general description of research and development programs, including research areas of interest in the announcement.)
Due Dates: Open continuously from Oct. 01, 2015 through Sept. 30, 2016. Organizations are required to submit pre-proposals/pre-applications. 
Amount & Project Period: Budgets are not limited - up to 5 years
Eligibility: All individuals, regardless of ethnicity, nationality, or citizenship status, employed by, or affiliated with, an eligible organization.
Contact: Office of Sponsored Research (x6804)
NEW Link: W81XWH-16-R-BAA1 (Rev 1) 


Rolling All Ranks Non-federal Pediatric

Thrasher Research Fund
E.W. "Al" Thrasher Awards

Ideal applications address significant health problems that affect children in large numbers and offer the potential for practical solutions to these problems. Such solutions sh/be innovative and have potential for broad applicability w/low financial and/or technical barriers to implementation. Hypothesis-driven research is preferred over exploratory, hypothesis-generating research. Projects with a shorter distance to clinical applicability are given priority.
Due Dates: Concept papers accepted on a rolling basis, and time from submission to decision is 1-6 weeks.  Submission of full proposal is allowed up to 1 year after approval of concept.  Review and response on proposal can take about 4 months.  Proposals and reviews are submitted to Committees at the beginning of February and August and final decisions are made in late Mar. and late Sept. 
Amount & Project Period: Grant amount is based on the actual budgetary needs of the project - Up to 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidance


NEW
Rolling (LOI) All Ranks Non-Federal Investigator-Initiated

Evidence for Action
Investigator-Initiated Research to Build Culture of Health

The goal of the program is to funds research that expands the evidence base needed to build a Culture of Health.  The mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.
Due Dates: Rolling Submission (LOI)
Invited Applications:  Notified within 6-8 weeks of LOI submission; Two months to submit full proposal after notification
Amount & Project Period: Application budget are not limited - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Guidelines


August 26 Postdocs/Junior Faculty Non-federal Career Development

American Gastroenterological Association
Research Scholar Award

This award enables young investigators, instructors, research associates or equivalents to develop independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research.
Due Dates: Aug. 24 (OSR) Ι August 26 (Sponsor)
Amount & Project Period: $270,000 (Total) - 3 years
Eligibility: Must hold a full-time faculty position by July 1, 2017;
MD applicants: no more than 7 years shall have elapsed following completion of clinical training (GI fellowship or its equivalent) and start date of this award.
PhD applicants: no more than 7 years shall have elapsed following award of PhD and start date of this award.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι American Gastroenterological Association




NEW
August 29  Postdocs/Research Scientists  Non-Federal  Career Development 

Society for Immunotherapy of Cancer 
SITC-Bristol-Myers Squibb Cancer Immunotherapy Translational Fellowship

An opportunity for young investigators to catalyze their research and advance the science and application of cancer immunotherapy.
Due Dates: Aug. 25 (OSR) Ι Aug. 29 (Sponsor)
Amount & Project Period: $200,000 - 2 years
Eligibility: MD or combined MD/PhD w/position of post-doctoral fellow, resident, research scientist or faculty w/in postdoc or postgraduate training, or <4 years from completing
Must commit 75% research effort to fellowship
Must be current SITC member ($240/faculty, $50/trainees)
Contact: Office of Sponsored Research (x6804)
Link: Guidelines

August 31 See Below Non-federal Career Development

Lymphoma Research Foundation
2017 Young Investigator Grants

Due Dates: Aug. 29 (OSR) Ι Aug. 31 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: Available Grant Opportunities
 

Postdoctoral Fellowships

This grant is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma.
Amount & Project Period: $105,000 - 2 years
Eligibility: Must hold an MD, PhD, or equivalent.
All applicants should not have completed > 5 years of their fellowship or postdoctoral work at start of award period.
Must spend a minimum of 80% effort on research
Link: Guidelines and General Instructions for Application

Clinical Investigator Career Development Awards

The goal of the program is to prepare physician investigators to design and administer clinical research studies in lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB) submission and publication.
Amount & Project Period: $225,000 - 3 years
Eligibility: Must be licensed physicians;
Clinical researchers w/in 5 years of completing postdoctoral training; 
Supported by an institutional mentor, grantee must spend at least 35% effort in independent clinical research;
May not simultaneously receive another competitive CDA
Link: Guidelines and General Instructions
 

Lymphoma Clinical Research Mentoring Program (LCrmp)  

This is an education and mentoring program for fellows and junior faculty with a focus in clinical research in the field of non-Hodgkin and Hodgkin lymphoma. The program offers a broad education on clinical research and career development as well as managing career and quality of life issues. Program goals include:
Provide mentoring and education to hematology/oncology fellows and junior faculty.
Assist in development of a specific clinical trial in patients with lymphoma and set foundation for grant development to support the trial.
Provide continuing training, career development advice, and mentorship among trainees and experts in the field and to foster future participation and collaboration within the LRF through follow-up programming and activities.
Amount & Project Period: $10,000 over 2 years to cover educational support such as tuition, registration fees, and travel for courses & meetings integral to the Career Development Plan, as well as supplies (such as computer hardware or software) or clinical trial expenses that will aid in professional development and/or project completion.
Eligibility: Must be a junior faculty member in the first 4 years of a faculty position or trainees in at least the second year of one of the following ACGME accredited sub-specialty fellowship programs: Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology, or Hematopathology. Applicants should not be >4 years beyond completion of a fellowship or >12 years beyond completion of MD or equiv. degree.
Link: 2017-2019 Program Overview, Guidelines & Instructions


NEW
September 01 (LOI) See Specific Announcement Non-Federal Career Development

Career Development Program

The purpose of the CDP is to enhance the careers of scientists researching blood cancer or normal blood cell biology that has relevance to blood cancer. LLS offers the opportunity to take part in translational, basic and clinical research, as well as technological and informatics development; however, all approaches must have direct blood cancer relevance.

Career development awards are available for various stages of your research career.
Due Dates: Sept. 01 (LOI)
Full Applications: Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Amount & Project Period: Scholar - ($110,000/yr -  5 years)
Scholar in Clinical Research - ($110,000/yr - 5 years)
Special Fellow -  ($67,000/yr - 2-3 years)
Fellow -  ($60,000/yr - 3 years)
Eligibility: Letter of intent is used to determine eligibility
Eligibility Phase open from July - Sept 1, 2016
Contact: Office of Sponsored Research (x6804)
Link: Career Development Program


NEW
September 01 (LOI) All Ranks Non-Federal Discovery

Pioneering Ideas Brief Proposal  
Reinventing Discovery

The goal of the program is to explore; to look into the future and put health first as we design for changes in how we live, learn, work and play. Preferably projects that pilot or use tools which help to share data and promote open science, and also emphasize the value of patient and citizen engagement to health and medical discovery.
Due Dates: Sept. 01 (LOI)
Invited Applications:  Notified within 6 weeks
Amount & Project Period: $250,000 total cost, 12-18 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview


September 01 See Below Non-federal Career Development

PhRMA Foundation
2017 Awards
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (Sponsor)
Eligibility: See specific announcements below
Contact: Office of Sponsored Research (x6804)
Primary Link: 2017 Awards

  Postdoctoral Fellowships - Post Doctoral Fellowships provide stipend support to well-trained graduates from Ph.D. programs seeking to further develop and refine their research skills through formal postdoctoral training.

Informatics - To support the post-doctoral career development of individuals preparing to engage in research that will bridge the gap between experimental and computational approaches in genomic and biomedical studies ($80,000 - 2 years)

Adherence Improvement - To provide stipend support for individuals engaged in a research training program that will extend their credentials in adherence improvement. To support the postdoctoral career development of individuals prepared to engage in research that will strengthen representation of adherence improvement in schools of pharmacy, medicine, nursing, and public health. ($50,000 - 1 year)

Pharmaceutics - Pharmaceutics is the science that deals with drug delivery systems - in particular, the design and evaluation of contemporary pharmaceutical dosage forms and systems to ensure their safety, efficacy, and reliability. ($40,000 - 1 year)

Pharmacology / Toxicology - support career development activities of scientists embarking on research that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, in experimental animal or clinical studies or both. ($40,000 - 1 year)

Research Starter Grants - offer financial support to individuals beginning independent research careers at the faculty level.

Adherence Improvement - to support research that will advance knowledge of innovative and effective approaches to improve medication adherence. Relevant research goals may include development or evaluation of policies, interventions, or tools that have potential to improve medication adherence. ($50,000 - 1 year)

Informatics - to promote development and use of informatics in an integrative approach toward understanding normal processes of human biology and disease processes. ($100,000 - 1 year)

Pharmaceutics - strongly emphasizes quantitative understanding and use of the principles underlying drug delivery and drug transport, whether a drug is a small organic molecule, a higher molecular weight peptide, a protein derived through biotechnology, or an oligonucleotide-like molecule for gene therapy. ($100,000 - 1 year)

Pharmacology / Toxicology -support career development activities of scientists embarking on research that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, in experimental animal or clinical studies or both. ($100,000 - 1 year)



September 01 All Ranks Non-federal Clinical Oncology

Impact Award

This award is a funding program from the Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of such projects.   Proposed work should use resources from completed SWOG trials or be directly translatable to future clinical trials in SWOG and the National Clinical Trials Network (NCTN). Studies may involve scientific risk but potentially lead to a breakthrough in a particular area, or to development of novel techniques, agents, methodologies, models, or applications that could have a major impact on cancer research.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (5:00, pm ET) (Sponsor)
Amount & Project Period: Up to $250,000 (TOTAL) - 2 years
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program.
Basic Science applicants are required to partner with a clinician as a Co-PI.
Contact: Office of Sponsored Research (x6804)
Links: Impact Award Ι Guidelines
R01 NIH
NCI is a participating institute
September 01 (LOI) All Ranks Federal Adverse Drug Reactions

Serious Adverse Drug Reaction Research

This FOA supports research grants that will advance the state of knowledge of serious adverse drug reactions.
Due Dates: Sept. 01 (Letter of Intent)
Applications Due: Sept. 30 (OSR) Ι Oct. 04 (Sponsor) Additional Due Dates:  Feb. 1; June 1; Oct. 2, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-275
Companion FOA: PAR-16-274 (R21)
DP1 NIH

Division of Program Coordination, Planning and Strategic Initiatives, Office of Strategic Coordination

 
September 02 All Ranks Federal Major Biomedical or Behavioral Challenges

NIH Director's Pioneer Award Program

These awards support individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges having potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness and disability.  To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator's research program or elsewhere.
Due Dates: Aug. 31 (OSR) Ι Sept. 02 (Sponsor)
Amount & Project Period: $700,000/yr. (Direct Costs) - 5 years  
Eligibility: All Ranks - Only single PD/PI applications are allowed.
Pioneer awardees are required to commit at least 51% of their research effort to activities supported by the Pioneer Award research project in the first three years of the project period.
Awardees will be allowed to reduce effort to 33% and 25% in the fourth and fifth years, respectively, to help them transition to other sources of support.
Applicants with current research commitments exceeding 49% must provide a detailed explanation describing how their effort on existing grants will be adjusted to permit them to devote the required minimum effort to the Pioneer Award project. 
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-16-005
R43/R44 NIH
NCI is a participating institute
September 05 See Below Federal SBIR/STTR

PHS 2016-02 Omnibus Solicitation of the NIH, CDC, FDA, and ACF for Small Business Innovation Research Grant Applications (Parent SBIR)  

This FOA invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, FDA or ACF awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics.
Due Dates: Sept. 05 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: Phase I:  $150,000 - 6 months
Phase II: $1,000,000 - 2 years
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Contact: Office of Innovation and Industry Alliances (x6828)
FOA Link: PA-16-302
Companion FOA: PA-16-303 STTR R41/R42- Phase I, Phase II, and Fast Track
R43/R44 NIH
NCI is a participating institute
September 05 See Below Federal Cell Line Identification

Tools for Cell Line Identification

This FOA will support SBIR projects to improve existing technologies, and/or develop novel, reliable, and cost effective tools that will make it easier for researchers to confirm the identity and/or sex of the cells that they use in their work.  Applications for support of research and development of particular types of complex technologies that require funding levels and durations beyond those reflected in standard SBIR guidelines are encouraged, as are multi-PD/PI applications, including multi-PD/PI applications that arise from academic-industrial partnerships.
Due Dates: Sept. 05 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: Phase I:  $150,000 - 6 months
Phase II: $1,000,000 - 2 years
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Contact: Office of Innovation and Industry Alliances (x6628)
FOA Link: PA-16-186
K12 NIH
NCI is a participating institute

NEW
September 06 (LOI) All Faculty Ranks Federal Career Development

Building Interdisciplinary Research Careers in Women's Health

This FOA invites institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs, hereafter termed "Programs". Programs will support mentored research career development of junior faculty members, known as BIRCWH Scholars, who have recently completed clinical training or postdoctoral fellowships, and who will be engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services research relevant to women's health, and, where appropriate, the use of both sexes to better understand the influence of sex as a variable on health and disease.
Due Dates: Oct. 04 (OSR) Ι Oct. 06 (Sponsor)
Amount & Project Period: $500,000 (Direct Costs) - 5 years
Eligibility: PD/PI sh/be established investigator in scientific area in which application is targeted and capable of providing administrative and scientific leadership to development and implementation of program.
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-OD-16-013
R01 NCI

September 08 (LOI) All Ranks Federal RNA Modifications

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization

This FOA invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.
Due Dates: Sept. 08 (Letter of Intent)
Application Due:  Oct.05 (OSR) Oct. 07 (Sponsor)
Additional Due Dates:  Apr. 11 and Oct. 10, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-317
Companion FOA: PAR-16-318 (R21)


September 09 (Concept paper) Postdocs/Fellows/Junior Faculty Non-Federal Career Development

Thrasher Research Fund
Early Career Awards

The purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers. The Fund is particularly interested in applicants that show great potential to impact that field of children's health through medical research.
Due Dates: Sept. 09 (Concept Paper)
Invited Submissions: Oct. 26 (OSR) Ι Oct. 28 (Sponsor)
Amount & Project Period: $25,000 (Direct Costs) - Up to 2 years
Eligibility: Physicians in residency/fellowship training program, or having completed that program <1 year before date of submission of Concept Paper;
Post-doctoral researchers having received doctoral degree <3 years prior to date of submission of Concept Paper;
Must be under the guidance of a mentor
Contact: Office of Sponsored Research (x6804)
Link: Early Career Awards
DP2 NIH
Division of Program Coordination, Planning and Strategic Initiatives, Office of Strategic Coordination


September 09 Junior Faculty Federal Major Biomedical or Behavioral Challenges

NIH Director's New Innovator Award Program

This award initiative supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches having potential to produce a major impact on broad, important problems in biomedical and behavioral research.
Due Dates: Sept. 07 (OSR) Ι Sept. 09 (Sponsor)
Amount & Project Period: $1,500,000 (Direct Costs) - 5 years
Eligibility: Applicants must meet the definition of an Early Stage Investigator (ESI).
Multiple PD(s)/PI(s) are not allowed
Applicants must hold an independent research position at a domestic (U.S.) institution as of September 1, 2017
Investigators still in training or mentored status (postdoctoral fellows) are not eligible unless they have a written commitment of an independent faculty position as of September 1, 2017
PI is required to commit at least 25% research effort each year to activities supported by the New Innovator Award.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-16-004


NEW
September 12 (LOI) Junior Faculty Non-Federal Transformative Research

NextGen Grants for Transformative Cancer Research

 This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected for these grants to catalyze significant scientific discoveries and help talented young investigators gain scientific independence.
Due Dates: Sept. 12 (LOI)
Invited Applications:  Dec 15 (OSR) Ι Dec. 19 (Sponsor)
Amount & Project Period: $450,000 total cost - 3 years
Eligibility: AACR membership is required.
Must have a doctoral degree (PhD, MD, PharmD or equivalent) in a related field and not currently a candidate for a further degree
Must hold a tenure-eligible appointment or equivalent at the rank of assistant professor by start of grant
Have held a tenure-eligible assistant professor appointment no more than 3 years (Not prior to July 2, 2014)
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Guidelines
R01 NIH
NCI is a participating Institute

NEW
September 14 (LOI)  All Faculty Ranks  Federal  Career Development 

International Tobacco, and Health Research and Capacity Building Program

This FOA solicits applications to support collaborative research projects addressing the health burden of tobacco use in low-and middle-income countries (LMICs). Trans-disciplinary research in LMICs may be proposed, w/overall goal of reducing the global burden of morbidity and mortality caused by tobacco use.
Due Dates: Sept. 14 (Letter of Intent)
Oct. 11 (OSR) Ι Oct. 13 (Sponsor)
Amount & Project Period: $250,000/yr. (Direct Costs) - 5 years
Eligibility: PDs/PIs from U.S. institution required to collaborate w/an investigator(s) from one or more LMIC institutions.
Scientists from U.S. submitting application w/partner in UMIC are required to have an additional lower-middle or low-income country partner.
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-TW-16-003



September 14 (LOI) All Ranks Federal PCOR

Patient-centered Outcomes Research Institute
Community-based Palliative Care Delivery for Adult Patients with Advanced Illnesses and their Caregivers

The overarching goal is to generate needed Comparative Effectiveness Research (CER) evidence to: a) support care planning over time that is consistent with the goals and preferences of adult patients with advanced illnesses and their caregivers, and b) support the delivery of coordinated, community-based palliative care that effectively implements those care plans.
Due Dates: Sept. 14 (Letter of Intent)
Full Applications Due:  Dec. 15 (OSR) Ι Dec. 19 (Sponsor)
Amount & Project Period: Total Direct Costs:
Advance Care Planning: Not to exceed $6M per study;
Models of Palliative Care Delivery: Not to exceed $10M per study
Period of Performance:  Up to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PCORI Funding Announcement

with NIGMS
September 14 All Ranks Federal Biological & Mathematical Sciences

Joint DMS/NIGMS Initiative to Support Research at the Interface of The Biological and Mathematical Sciences (DMS/NIGMS)

This initiative will support research in mathematics and statistics on questions in biological and biomedical sciences.  Both agencies recognize the need and urgency for promoting research at the interface between mathematical and life sciences. The program is designed to encourage new collaborations, as well as to support existing ones.
Due Dates: Sept. 12 (OSR) Ι Sept. 14 (Sponsor)
Amount & Project Period: $100,000 to $400,000/yr. (TOTAL) for 3 - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview | Program Solicitation


Cycle 3 - Pre-
announcement
September 14 (LOI) All Ranks Non-federal PCOR

Patient-Centered Outcomes Research Institute
Upcoming Opportunities - Cycle 3 2016

 This posting provides initial information about upcoming Cycle 3 2016 funding opportunities.
Due Dates: Sept. 14 (Letter of Intent)
Applications Due: Dec. 15 (OSR) Ι Dec. 19 (Sponsor)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes
 
Improving Methods for Conducting Patient-Centered Outcomes Research

Communication and Dissemination Research - Cycle 3 2016
 
Improving Healthcare Systems - Cycle 3 2016

Assessment of Prevention, Diagnosis, and Treatment Options - Cycle 3 2016

Addressing Disparities - Cycle 3 2016


NEW
September 14 (Pre-application) All Ranks Federal Breast

Congressionally Directed Medical Research Programs
Breast Cancer Research Program  
Breakthrough Award Levels 3 & 4  
W81XWH-16-BCRP- BREAKTHROUGH2_FL34

The intent is to support promising research with high potential to lead to or make breakthroughs in breast cancer. Proposals will have potential for a major impact and acceleration of progress toward ending breast cancer; the scope may be small- to large-scale projects, at different stages of idea and research development. Includes Partnering PI Option.
Due Dates: Sept. 14 (Pre-application)
Invited Submissions: Dec. 06 (OSR) Ι Dec. 08 (Sponsor)
Amount & Project Period: The funding level should be selected based on scope of research project.  
Level 3:  $2.5M (Direct Costs) - 4 years
Level 3 (Ptnr. PI):  $4.0M - 4 years (Separate awards to each PI's institution)
Level 4 (Single or Ptnr. PI):  $10.0M - 4 years
Notes: An invited oral presentation is a requirement for application review of Funding Level 4 projects.
Eligibility: Independent Investigators at all academic levels (or equiv.) Investigators invited to submit an application under W81XWH-16-BCRP-BREAKTHROUGH_FL34 are not eligible to submit a pre-application for the same research project under the current announcement.
Contact: Office of Sponsored Research (x6804)
Link: BCRP FY16 BTA34 2 PA GG.PDF (Click on related documents)


September 15 Junior Faculty Non-federal Career Development

Alfred P. Sloan Foundation
Sloan Research Fellows

The Foundation makes grants to support original research and broad-based education related to science, technology, and economic performance; and to improve the quality of American life. The Foundation is interested in projects that it expects will result in a strong benefit to society, and for which funding from the private sector, the government, or other foundations is not widely available.   The Sloan Research Fellowships seek to stimulate fundamental research by early-career scientists and scholars of outstanding promise.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: $60,000 - 2 years
Eligibility: Must hold a tenure track (or equiv.) position Tenure track faculty positions must include a yearly teaching requirement;
Must hold a Ph.D. (or equiv.) in chemistry, computational or evolutionary molecular biology, computer science, economics, mathematics, neuroscience, physics, or a related field; Candidates' most recent Ph.D. (or equiv.) must have been awarded on or after September 1, 2010.  Exceptions may apply. 
Contact: Office of Sponsored Research (x6804)
Links: 2016 Sloan Research Fellows Ι About the Foundation


September 15 (Pre-app.) All Faculty Ranks Federal Prostate/Clinical Research

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program
Prostate Cancer Clinical Consortium Research Site Award
W81XWH-16-PCRP-CCRSA

This Award provides support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials.  In accordance with PCRP goals, conduct of Phase I/II trials incorporating investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.
Due Dates: Sept. 15 (Pre-application)
Applications Due: Oct. 04 (OSR) Ι Oct. 06 (Sponsor)
Amount & Project Period: $800,000 (Direct Costs) - 4 years (See PA for addnl. information on out-years)
Eligibility: Independent investigators at Assistant Professor level (or equiv.) or higher
Contact: Office of Sponsored Research (x6804)
Links: FY16 Prostate Cancer Research Program (PCRP)
W81XWH-16-PCRP-CCRSA (Program Announcement)
UG3/UH3 NCI

September 15 (LOI) All Ranks Federal Informatics

New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research

This FOA seeks applications for projects to develop, adapt, apply, scale-up, and validate tools and methods to improve collection and integration cancer registry data and to expand the data items collected.  Scientific scope includes but is not limited to:
1.  Development, validation, evaluation of scalable tools/methods to facilitate
      automatic/unsupervised extraction of specific data from various types of unstructured
      medical records as for example,  pathology reports, diagnostic imaging, laboratory,
      discharge and clinical visits;
2.  Supplementation of cancer registries with new or more detailed data items, from existing
     data sources or from linkages with novel data sources, e.g. electronic medical records
     (EMR).
Due Dates: Sept. 15 (Letter of intent)
Oct. 12 (OSR) | Oct. 14 (Sponsor)
Additional Due Dates:  Apr. 14 & Nov. 30, 2017
Amount & Project Period: Application budgets must reflect actual needs of proposed project but must not exceed $600,000 [i.e., no more than $300,000 direct costs/ year for the first 2 years] during UG3 phase and $1,500,000 [i.e., no more than $500,000 direct costs/ year for the last 3 years] during UH3 phase. - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-349
ata sources or from linkages with novel data sources, e.g. electronic medical records (EMR).
R21/R33 NIH
NCI is a participating institute
September 16 (LOI) All Ranks Federal Treatment Outcomes

Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes

This FOA encourages applications that focus on early-stage, treatment generation and pilot clinical trials that are consistent with an experimental therapeutic approach. This approach requires the identification of a theory-derived target based on putative mechanisms of alcohol, tobacco and other drug use, and clear hypotheses about how a treatment directed at changing the target can lead to clinical benefits.
Due Dates: Sept. 16 (Letter of Intent)
Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: The R21 phase:  $275,000 (Direct costs) - 2 years.
The R33 phase:  Budgets not limited - 3 years.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-353
Companion FOA: PAR-16-352, R33 Exploratory/Developmental Phase II
R01 NHGRI
National Human Genome Research Institute

 
September 20 (LOI) All Ranks Federal Genome Sequencing

Investigator-Initiated Clinical Sequencing Research

Research objectives are to stimulate innovation and advance understanding of when, where and how best to implement clinical genome sequencing.  The FOA encourages targeted scientific research studies focused on advancing use of clinical genome sequencing in genomic medicine, including, but not limited to, studies of whether and how clinical genome sequencing impacts disease diagnosis and treatment, research to address current barriers to implementation of clinical genome sequencing, and approaches to improve identification and interpretation of genomic variants in clinical settings.
Due Dates: Sept. 20 (Letter of Intent)
Applications Due:  Oct. 18 (OSR) I Oct. 20 (Sponsor)
Amount & Project Period: Application budgets are not limited - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-209


NEW
September 23 (LOI) Established Faculty Non-Federal Hematological Malignancies

Specialized Center of Research Program

The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. To bring together established investigators from one or several institutions to develop a focused research program and enhance interdisciplinary research.
Due Dates: Sept. 23 (LOI)
Invited Applications: Feb. 27 (OSR) Ι Mar. 1 (Sponsor)
Amount & Project Period: $1,000,000/yr - 5 years (total cost)
Eligibility: Must hold a PhD, MD, DVM or equivalent
Must be affiliated with a non-profit institution
Contact: Office of Sponsored Research (x6804)
RFA Link: Specialized Center of Research Program


September 27 All Ranks Federal Mathematics

Directorate for Mathematical & Physical Sciences
Division of Mathematical Sciences
Focused Research Groups in the Mathematical Sciences (FRGMS)  

The purpose of this activity is to support collaborative groups employing innovative methods to solve specific, major research challenges in the mathematical sciences.  A major challenge is an outstanding problem of significant importance that requires the focused and synergistic efforts of a collaborative group to solve, and whose solution will have wide impacts in the mathematical sciences and potentially in other areas. Risky projects are welcome. Interdisciplinary projects are welcome.
Due Dates: Sept. 23 (OSR) Ι Sept, 27 (Sponsor)
Amount & Project Period: $150,000 to $500,000/yr. - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: NSF 16-577

with NIH
NCI is a participating institute
September 28 All Ranks Federal Biomedical Big Data

Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data  (QuBBD)  

The National Science Foundation(NSF) and the National Institutes of Health (NIH) recognize that fundamental questions in basic, clinical, and translational research could benefit greatly from multidisciplinary approaches that involve experts in quantitative disciplines such as mathematics, statistics, and computer science.  This program is designed to support research that addresses important application areas at the intersection of the biomedical and data sciences by encouraging inter- and multi-disciplinary collaborations that focus on innovative and transformative approaches to address these challenges.
Due Dates: Sept. 26 (OSR) Ι Sept. 28 (Sponsor)
Amount & Project Period: $200,000 to $300,000/yr.  (Total) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: 16-573 | Program Page


October 03 Postdocs non-federal Career Development/Immunology

Cancer Research Institute Irvington
Postdoctoral Fellowships

Fellowships provide support to fund and train young immunologists and cancer immunologists.  Hypothesis-driven, mechanistic studies in both immunology and tumor immunology are sought.
Due Dates: Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Amount & Project Period: Stipend:  $55,000 (yr. 01); $57,000 (yr. 02); and $59,000 (yr. 03) Allowance: $1,500/yr.
Eligibility: Must have doctoral degree by date of award activation
Must have less than 5 years of relevant experience
Must have spent less than 3 years in sponsor's laboratory
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Application Guidelines
Research Supplement NIH
NCI is a participating institute

See Below See Below Federal Career Development

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers

The purpose of these supplements is to encourage individuals to re-enter research careers w/in the missions of all program areas of NIH.  Supplements to existing NIH research grants will be made to support full-time or part-time research by these individuals to update their existing research skills and knowledge.
Due Dates: NCI accepts applications from October 1 to December 1 Additional Submission Period:  February 1 to March 30
Amount & Project Period: See NCI Re-Entry Supplements Guidelines
Eligibility: At time of supplement application, parent grant must have at least 2 years of NCI support remaining.  NCI does not accept P30 as parent grant for Re-Entry Supplement. 
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-289
Companion FOA: PA-16-288 Research Supplements to Promote Diversity in Health-Related Research
NCI Diversity Supplements Guidelines


October 04 All Ranks Federal Mathematical Analysis

National Science Foundation Division of Mathematical Sciences
Analysis Program

Research supported by the Analysis Program provides the theoretical underpinning for the majority of applications of the mathematical sciences to other scientific disciplines.
Due Dates: October 02 (OSR) Ι OCT. 04 (Sponsor)
Amount & Project Period: Budget not limited - 3 to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: PD 16-1281 Ι Grant Proposal Guide Ι Mathematical Sciences
R01 NCI
October 05 All Ranks Federal HPV Vaccine

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake

This FOA encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: Application budgets should reflect actual needs of proposed project - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-338
Companion FOAs: PAR 16-336 (R21) Ι  PAR-16-337 (R03)
R01/R21 NIH
NCI is a participating Institute

NEW
October 05 All Ranks Federal Palliative Care/AYA

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses

Research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults w/serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers.
Due Dates: Standard Dates
R01: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Amount & Project Period: R01: Budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PA-15-324
Companion Link: PA-15-325 (R21)
R01 NCI

NEW
October 05 All Ranks Federal Pediatric Sarcoma

Gene Fusions in Pediatric Sarcomas

The purpose of this FOA is to encourage applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PA-16-251
Companion FOA: PA-16-252 (R21)
R01 NIH
NCI is a participating institute

NEW
October 05 All Ranks Federal Nutrition and Omics

Nutrigenetics and Nutrigenomics Approaches  for Nutrition Research

The purpose of this Funding Opportunity Announcement (FOA) is to promote application of nutrigenetics and/or nutrigenomics approaches to nutrition research through collaborative interaction among nutrition researchers and experts in omics technologies.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PA-16-O332
R01 NCI

NEW
October 05 All Ranks Federal Dissemination & Implementation

Dissemination and Implementation Research in Health  

This FOA encourages applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-238
Companion FOAs: PAR-16-236 (R21)
PAR-16-237 (R03)
R01 NBIB
NCI is a participating institute

NEW
October 05 All Ranks Federal Bioengineering

Neural Regulation of Cancer

NCI encourages applications for research to gain understanding and achieve mitigations and solutions to cancer problems.  Interests in understanding, mitigations, solutions, and dissemination of knowledge and methods cover: cancer basic knowledge on what it is, causes and prevention, risk factors, screening, diagnosis and staging, monitoring, prognosis, symptoms, finding care givers and treatment facilities, types of treatment, side effects, clinical trials including information for caregivers and patients, cancer drugs, complementary and alternative medicine, among other interests.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-242
R01 NIH

Division of Program Coordination, Planning and Strategic Initiatives, Office of Strategic Coordination

 

 

October 07 All Ranks Federal Original, Unconventional Projects

NIH Director's Transformative Research Awards

These awards support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
Due Dates: Oct. 05 (OSR) Ι Oct. 07 (Sponsor)
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-16-007
R01 NCI

NEW
October 07 All Ranks Federal Cancer and Behavior

Predicting Behavioral Responses to Population-Level Cancer Control Strategies

The goal is to facilitate research to identify individual influences on the effectiveness of population-level strategies that target cancer-related behaviors. Collaborations among scientists with expertise in health policy research and implementation, as well as investigators in scientific disciplines that have not traditionally conducted cancer or policy research, such as: psychological science (e.g., social, developmental); affective and cognitive neuroscience; judgment and decision-making; consumer behavior and marketing; organizational behavior; sociology, cultural anthropology; behavioral economics; linguistics; and political science are encouraged.
Due Dates: Oct. 05 (OSR) Ι Oct. 07 (Sponsor)
Additional Due Dates:  Apr. 11 & Oct. 10, 2017
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-257
R01 NCI

NEW
October 11 All Ranks Federal Smoking Cessation

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions

This FOA is intended to stimulate research efforts aimed at development of smoking cessation interventions that: 1) are targeted to socioeconomically disadvantaged populations, and 2) could be made scalable for broad population impact.
Due Dates: Oct. 07 (OSR) Ι Oct. 11 (Sponsor)
Additional Due Dates: June 13 & Oct. 11, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-202
Companion FOA: PAR-16-201, R21 Exploratory/Developmental Grant (This FOA provides funding for up to 2 years for protocol development and early phase, pilot, or exploratory projects.)
R01 NCI

NEW
October 11 All Ranks Federal Neural Regulation

Innovative Approaches to Studying Cancer Communication in the New Media Environment

This FOA invites applications seeking to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life.
Due Dates: Oct. 07 (OSR) Ι Oct. 11 (Sponsor)
Additional Due Dates:  June 13, & Oct.  11, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-249
Companion FOA: PAR-16-248, R21
R01 NCI

NEW
October 13 All Ranks Federal Cognitive Impairment

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

This FOA encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as, chemobrain. A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.
Due Dates: Oct. 11 (OSR) Ι Oct. 13 (Sponsor)
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-212
Companion FOA: PAR-16-213 (R21)
R21 NCI

NEW
October 13 All Ranks Federal Behavioral Interventions

Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection

This FOA provides support for development of innovative interventions to improve cancer-related health behaviors across diverse racial/ethnic populations. Specifically, it is intended to stimulate research aimed at 1) testing new theories and conceptual frameworks; 2) developing and evaluating novel strategies to improve cancer-related health behaviors; 3) investigating multi-level and multi-behavioral approaches; and 4) utilizing innovative research designs, methodologies, and technologies.
Due Dates: Oct. 11 (OSR) Ι Oct. 13 (Sponsor)
Additional Due dates:  June 13 & Oct. 13, 2017
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-276
Companion FOA: PAR-16-277 (R21)
Admin Supplement NIH
NCI is a participating institute

NEW
October 15 See Below Federal DIetary Supplments

Administrative Supplements for Research on Dietary Supplements

This FOA supports research in which supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Primary consideration for support will be given to applications that stimulate dietary supplement research where it is lacking or lagging, clarify gaps, opportunities and balance between benefits and risks where data are in conflict, target special population groups where additional science on dietary supplements is needed, and focus on the use of dietary supplements in improving or maintaining health and reducing the risk of chronic disease.
Due Dates: Oct. 13 (OSR) Ι Oct. 15 (Sponsor)
Additional Due Dates:  Jan. 15 or Apr. 15, 2017
Amount & Project Period: $100,000 (Direct Costs) - 1 year
Eligibility: Active awards w/at least 18 months remaining at time of submission will be considered.  Awards in no-cost extension periods are not eligible.
Contact: Office of Sponsored Research (x6804)
Link: PA-16-319
R21/R33 NIH
NCI is a participating institute

NEW
October 16 All Ranks Federal Aging-Interdisciplinary Studies

Research Infrastructure Development for Interdisciplinary Aging Studies

This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. 
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor) 
Additional Due dates:  Standard dates
Amount & Project Period: R21 phase:  $275,000 (Direct Costs) - 2 years
R33 phase:  Budgets must remain under $500,000/yr.  
(Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-367
Companion FOA: PAR-16-368  (R33)
R21 NCI

NEW
October 16 All Ranks Federal RNA Modifications

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology

This FOA encourages basic research into the role of RNA chemical modifications and their corresponding writers, readers and erasers in the initiation and progression of cancer. This FOA will support investigation of novel scientific ideas or new model systems, tools or technologies that have the potential for significant impact on biomedical or biobehavioral research.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PA-16-177
R21 NCI

NEW
October 16 All Ranks Federal Symptoms & Toxicities

Mechanisms of Cancer and Treatment-related Symptoms and Toxicities

This FOA invites innovative pilot projects to stimulate research aimed to better understand the complex interaction of biological, cognitive, behavioral, and sociocultural factors contributing to cancer and treatment related symptoms and toxicities throughout the cancer care trajectory. Of particular interest is gaining new insights about these factors, either alone or in combination, in minority, underserved, the elderly, and pediatric and young adult populations.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PA-16-258
R21 NIH
NCI is a participating institute

NEW
October 16 All Ranks Federal Behavioral & Social Science Data

Methodology and Measurement in the  Behavioral and Social Sciences

To improve and develop methodology in the behavioral and social sciences through innovations in research design, measurement, data collection and data analysis techniques. Participating institutes encourage research that will improve the quality and power of behavioral and social science data relevant to the IC missions.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-261
Companion FOA: PAR-16-260 (R01)
R21 NCI

NEW
October 16 All Ranks Federal Behavioral Inerventions

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control

This FOA provides support for development of innovative interventions to improve cancer-related health behaviors across diverse racial/ethnic populations. Specifically, it is intended to stimulate research aimed at 1) testing new theories and conceptual frameworks; 2) developing and evaluating novel strategies to improve cancer-related health behaviors; 3) investigating multi-level and multi-behavioral approaches; and 4) utilizing innovative research designs, methodologies, and technologies.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-278
R03 NIH
NCI is a participating institute

NEW
October 16 All Ranks Federal Childhood Cancers

Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource

This FOA is intended to promote meritorious small research projects focused on the development and analyses of childhood cancer and/or structural birth defects datasets that are part of the Kids First Data Resource or could be included in the Kids First Data Resource. Development of statistical methodology appropriate for analyzing genome-wide data relevant to childhood cancer and/or structural birth defects may also be proposed.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: $100,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-348
R21 NIH
NCI is a participating institute

NEW
October 17 All Ranks Federal Metabolic Programming for Immunotherapy

Metabolic Reprogramming to Improve Immunotherapy

The purpose is to encourage applications to (a) generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, (b) determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and (c) then use this information to manipulate (reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy.
Due Dates: Oct. 13 (OSR) Ι Oct. 17 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-229
Companion FOA: PAR-16-228 R01
R21 NIH
NCI is a participating institute

NEW
October 17 (LOI) All Ranks Federal Health Disparities

Social Epigenomics Research Focused on Minority Health and Health Disparities

The purpose of this FOA is to support and accelerate innovative exploratory and developmental human epigenomic investigations focused on identifying and characterizing the mechanisms by which social experiences at various stages in life, both positive and negative, affect gene function and thereby influence health trajectories or modify disease risk in minority and health disparity populations.
Due Dates: Oct. 17 (Letter of Intent)
Nov. 11 (OSR) Ι Nov. 15 (Sponsor)
Additional Due Dates: Nov. 15, 2017 & 2018
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-356
Companion FOA: PAR-16-355  (R01)

Semi annual deadline

NEW 
October 17  See below  Non-Federal  Career Development 

Research and Training Grants

Mentored Research Grants: Overview Ι Guidelines
Postdoctoral Fellowship: Overview Ι Guidelines
Research Scholar Grant: Overview Ι Guidelines
Due Dates: Oct. 13 (OSR) Ι Oct. 17 (Sponsor)
Note: Paper copes are due one day after submission of electronic copy
Amount & Project Period: Mentored Research Scholar Grant: $135,000/yr. (Direct Costs) - 5 years
Postdoctoral Fellowships: Progressive stipends of $48,000, $50,000 and $52,000, plus a $4,000/yr. fellowship allowance - 3 years
Research Scholar Grant: $165,000/yr. (Direct Costs) - 4 years
Eligibility: See specific program announcement
Contact: Office of Sponsored Research (x6804)
Link: Grant Types  
 
October 17  Established Faculty Non-Federal  Pilot & Exploratory

Pilot and Exploratory Projects in Palliative of Cancer Patients and Their families

 The goal is to provide support for a small pilot or exploratory project whose purpose is to test interventions, develop research methodologies and explore novel areas. Research may focus on decision making, treatment, symptom control, team care, engaging family members and caregivers to address communication barriers and/or optimal symptom management.
Due Dates: Oct. 13 (OSR) Ι Oct. 17 (Sponsor)
Note: Paper copes are due one day after submission of electronic copy
Amount & Project Period: $60,000/yr. (Directo Costs) - 2 years
Eligibility: Full time faculty position or equivalent
Contact: Office of Sponsored Research (x6804)
RFA Link: Overview Ι Guidelines
U24 NCI

NEW
October 21 (LOI) All Ranks Federal HPV Vaccine

Advanced Development of Informatics Technologies for Cancer Research and Management

Applications are sought for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.
Due Dates: Oct. 21 (Letter of Intent)
Nov. 17 (OSR) Ι Nov. 21 (Sponsor)
Additional Due Dates: June 14 & Nov. 20, 2017
Amount & Project Period: Up to $600,000 Direct Costs (excluding consortium F&A costs)/yr. -  5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-15-331
Companion FOAs: PAR-15-334 - Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)
PAR-15-332  - Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
PAR-15-333 - Sustained Support for Informatics Resources for Cancer Research and Management (U24)
R01 NCI

NEW
October 26 All Ranks Federal Neural Regulation

Neural Regulation of Cancer

This FOA encourages collaborative, transdisciplinary research w/both neuroscience and cancer elements, together advancing current understanding of the nervous system contribution to cancer.
Due Dates: Oct. 24 (OSR) Ι Oct. 26 (Sponsor)
Additional Due Dates:  Feb.22, June 27, & Oct 26, 2017
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-245
Companion FOA: PAR-16-246 (R21)
 

NEW
October 26  All Ranks  Federal  Theoretical Physics & Cancer Biology 

National Science Foundation (NSF) Directorate for Mathematical & Physical Sciences Division of Physics  

Investigator-Initiated Research Projects (PHY) Physics of Living Systems

Focus should be on understanding basic physical principles that underlie biological function.  From Dear Colleague Letter below: The Physics Division, through the Physics of Living Systems program, accepts and reviews investigator-initiated proposals on the interdisciplinary topic of theoretical physics in cancer biology. Proposals may involve joint efforts between investigators from theoretical physics and researchers from the biomedical community, although the focus of the project must be on the role that physics plays in the effort.
Due Dates: Oct. 24 (OSR) Ι Oct. 26 (Sponsor)
Amount & Project Period: $90,000 (TOTAL Costs) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research(x6804)
Links: 16-566 Program Solicitation
Program Guidelines
Dear Colleague Letter: Submission of Proposals to NSF Programs that Address the Interdisciplinary Topic of Theoretical Physics Approaches to Cancer Biology


NEW
October 26 All Ranks Federal Living Systems

Division of Physics: Investigator-Initiated Research, Physics of Living Systems

This program targets synergy of theoretical and experimental research exploring the most fundamental physical processes that living systems utilize to perform their functions in dynamic and diverse environments. The focus of the research proposals should be on understanding basic physical principles that underlie biological function.
Due Dates: Oct. 24 (OSR) Ι Oct. 26 (Sponsor)
Amount & Project Period: Application budget is not limited
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: NSF-16-566 Ι Synopsis


NEW
October 31  See Below  Non-Federal  Ovarian Cancer 

Kaleidoscope of Hope Foundation  
General Research Grants and Young Investigator Grants  

Research proposals in the following areas will be considered: Early Detection of Ovarian Cancer incl. precursor cell studies and Treatment of Ovarian Cancer:  
General Research Grant proposals may be individual projects or part of a larger project related to ovarian cancer. Proposals for clinical trials must be original investigational studies related to ovarian cancer in which the grantee is the PI or co-PI.  
Young Investigator Grants support career development in the area of ovarian cancer research.
Due Dates: Oct. 27 (OSR) Ι Oct. 31 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: General Research Grants:  Established Investigators
Young Investigator:  Postdoc or Assist. Prof. w/in 5 years of completing terminal degree or Assistant professor (or equiv.) w/in 3 years of initiating independent research
Contact: Office of Sponsored Research (x6804)
Link: 2017 RFP Ι About Kaleidoscope of Hope
UG3/UH3 NIH
NCI is a participating institute

NEW
November 1 (LOI) See Below Federal Resilience in Multiple Contexts

Advancing Basic Behavioral and Social Research on Resilience: An Integrative Science Approach

This FOA solicits applications that will elucidate mechanisms and processes of resilience within a general framework that emphasizes its dynamics and interactions across both time and scale, multiple contexts, multiple outcomes, and multiple time frames. This framework can be applied to multiple contexts (e.g., acute or chronic stress exposure, including disease, disaster, unemployment, divorce, etc.), multiple outcomes (health, function, psychological well-being, etc.), and multiple time frames (seconds, minutes, days, years).
Due Dates: Nov. 01 (Letter of Intent)
Nov. 29 (OSR) Ι Dec. 01 (Sponsor)
Amount & Project Period: UG3 phase limited to $250,000/ year w/exception of studies incorporating well-justified pilot studies, in which case there is no budget limit.
UH3 phase is not limited must reflect actual needs of proposed project.
Combined Period of Performance - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-326


NEW
November 01 (LOI) Faculty Non-Federal Immunotherapies

Clinic and Laboratory Integration Program (CLIP)

The award provides funding for qualified scientists working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. Grants will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.
Due Dates: Nov. 01 (Letter of Intent)
Invited applications:  Jan. 30 (OSR) Ι Feb. 01 (Sponsor)
Amount & Project Period: $200,000 (Total) - 2 years
Eligibility: Tenure-track assistant (or higher) professor at time of award activation
No citizenship restrictions
Contact: Office of Sponsored Research (x6804)
Link: Overview
Application Guidelines


NEW
November  01
(Concept Paper)		 All Ranks  Non-Federal  Women's Reproductive Health Education 

Anna Lalor Burdick Grants Program

This program focuses particularly on young women who have inadequate access to information regarding reproductive health, including the subjects of contraception and pregnancy termination, and as such may be particularly lacking options in their lives.
Due Dates: Nov. 01 (Concept paper) Online portal will open one month prior to the concept paper deadline. Applicants will be informed w/in 6-8 weeks and if invited, will be provided instructions to prepare a full proposal.
Amount & Project Period: $15,000 to $25,000 - 1 year
Eligibility: All Ranks - Organizations may submit only one concept paper per round of funding (2 per year)
Contact: Office of Sponsored Research (x6804)  Please be sure to contact OSR immediately if you wish to submit a concept paper in order to remain in compliance with one submission per round.
Link: Overview Ι Guidelines Ι Application Instructions
R21 NIH
NCI is a participating institute

NEW
November 06 See Below Federal Pediatric Burkitt Lymphoma (BL)

Basic Biopsychosocial Mechanisms and Processes in the
Management of Chronic Conditions

 This FOA seeks to stimulate basic inquiry into the mechanisms that influence people within their larger social contexts to manage one or multiple conditions over the lifecourse.  NCI is interested in research examining how biological factors (such as stress reactivity, fatigue, depression, anxiety, anorexia) influence decision making related to sustaining adherence to cancer treatment.
Due Dates: Nov. 04 (OSR) Ι Nov. 06 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) -2 years
Eligibility: All Ranks
Project & budget periods must be w/in currently approved project period for existing parent award.
Proposed period may not include any anticipated period of no-cost extension of parent award.
Project period must not exceed 24 months
Contact: Office of Sponsored Research (x6804)
Link: PAR-16-095


NEW
December 01 See Below Non-Federal Career Development

Physician-Scientist Training Award

The goal of this pilot program is to provide protected research training experience under a mentorship and after all of clinical training has been completed. The goals are to a) transform individuals into quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer and b) to eliminate the financial disincentive to entering this career path.
Due Dates: Nov. 29 (OSR) Ι Dec. 01 (Sponsor)
Amount & Project Period: $460,000 total cost - overall 4 years
Eligibility: Must be Physician-scientist (MDs Only)
Must devote a minimum of 80% effort
Must have completed residence and clinical training
Must be U.S. Specialty Board eligible prior to start date
Not have more than 3 years of postdoc lab research experience NOTE: MD/PhDs are not eligible to apply
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Guidelines
Toolbox/strong/
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org